[1]
Utama, W.S. et al. 2024. Psoriasis vulgaris patient with psoriatic arthritis managed with interleukin-17A inhibitor: Balancing benefits and adverse effects. Narra J. 4, 1 (Jan. 2024), e207. DOI:https://doi.org/10.52225/narra.v4i1.207.